Global Bi-Specific MAbS Market Size, Status and Forecast 2021-2027
SKU ID : QYR-19408944 | Publishing Date : 27-Oct-2021
Detailed TOC of Global Bi-Specific MAbS Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bi-Specific MAbS Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Catumaxomab
1.2.3 Blinatumomab
1.2.4 Duligotumab
1.2.5 SAR 156597
1.3 Market by Application
1.3.1 Global Bi-Specific MAbS Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Inflammatory Diseases
1.3.5 Infectious Diseases
1.3.6 Microbial Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bi-Specific MAbS Market Perspective (2016-2027)
2.2 Bi-Specific MAbS Growth Trends by Regions
2.2.1 Bi-Specific MAbS Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bi-Specific MAbS Historic Market Share by Regions (2016-2021)
2.2.3 Bi-Specific MAbS Forecasted Market Size by Regions (2022-2027)
2.3 Bi-Specific MAbS Industry Dynamic
2.3.1 Bi-Specific MAbS Market Trends
2.3.2 Bi-Specific MAbS Market Drivers
2.3.3 Bi-Specific MAbS Market Challenges
2.3.4 Bi-Specific MAbS Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bi-Specific MAbS Players by Revenue
3.1.1 Global Top Bi-Specific MAbS Players by Revenue (2016-2021)
3.1.2 Global Bi-Specific MAbS Revenue Market Share by Players (2016-2021)
3.2 Global Bi-Specific MAbS Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bi-Specific MAbS Revenue
3.4 Global Bi-Specific MAbS Market Concentration Ratio
3.4.1 Global Bi-Specific MAbS Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bi-Specific MAbS Revenue in 2020
3.5 Bi-Specific MAbS Key Players Head office and Area Served
3.6 Key Players Bi-Specific MAbS Product Solution and Service
3.7 Date of Enter into Bi-Specific MAbS Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bi-Specific MAbS Breakdown Data by Type
4.1 Global Bi-Specific MAbS Historic Market Size by Type (2016-2021)
4.2 Global Bi-Specific MAbS Forecasted Market Size by Type (2022-2027)
5 Bi-Specific MAbS Breakdown Data by Application
5.1 Global Bi-Specific MAbS Historic Market Size by Application (2016-2021)
5.2 Global Bi-Specific MAbS Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bi-Specific MAbS Market Size (2016-2027)
6.2 North America Bi-Specific MAbS Market Size by Type
6.2.1 North America Bi-Specific MAbS Market Size by Type (2016-2021)
6.2.2 North America Bi-Specific MAbS Market Size by Type (2022-2027)
6.2.3 North America Bi-Specific MAbS Market Size by Type (2016-2027)
6.3 North America Bi-Specific MAbS Market Size by Application
6.3.1 North America Bi-Specific MAbS Market Size by Application (2016-2021)
6.3.2 North America Bi-Specific MAbS Market Size by Application (2022-2027)
6.3.3 North America Bi-Specific MAbS Market Size by Application (2016-2027)
6.4 North America Bi-Specific MAbS Market Size by Country
6.4.1 North America Bi-Specific MAbS Market Size by Country (2016-2021)
6.4.2 North America Bi-Specific MAbS Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Bi-Specific MAbS Market Size (2016-2027)
7.2 Europe Bi-Specific MAbS Market Size by Type
7.2.1 Europe Bi-Specific MAbS Market Size by Type (2016-2021)
7.2.2 Europe Bi-Specific MAbS Market Size by Type (2022-2027)
7.2.3 Europe Bi-Specific MAbS Market Size by Type (2016-2027)
7.3 Europe Bi-Specific MAbS Market Size by Application
7.3.1 Europe Bi-Specific MAbS Market Size by Application (2016-2021)
7.3.2 Europe Bi-Specific MAbS Market Size by Application (2022-2027)
7.3.3 Europe Bi-Specific MAbS Market Size by Application (2016-2027)
7.4 Europe Bi-Specific MAbS Market Size by Country
7.4.1 Europe Bi-Specific MAbS Market Size by Country (2016-2021)
7.4.2 Europe Bi-Specific MAbS Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bi-Specific MAbS Market Size (2016-2027)
8.2 Asia-Pacific Bi-Specific MAbS Market Size by Type
8.2.1 Asia-Pacific Bi-Specific MAbS Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bi-Specific MAbS Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bi-Specific MAbS Market Size by Type (2016-2027)
8.3 Asia-Pacific Bi-Specific MAbS Market Size by Application
8.3.1 Asia-Pacific Bi-Specific MAbS Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bi-Specific MAbS Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bi-Specific MAbS Market Size by Application (2016-2027)
8.4 Asia-Pacific Bi-Specific MAbS Market Size by Region
8.4.1 Asia-Pacific Bi-Specific MAbS Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bi-Specific MAbS Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bi-Specific MAbS Market Size (2016-2027)
9.2 Latin America Bi-Specific MAbS Market Size by Type
9.2.1 Latin America Bi-Specific MAbS Market Size by Type (2016-2021)
9.2.2 Latin America Bi-Specific MAbS Market Size by Type (2022-2027)
9.2.3 Latin America Bi-Specific MAbS Market Size by Type (2016-2027)
9.3 Latin America Bi-Specific MAbS Market Size by Application
9.3.1 Latin America Bi-Specific MAbS Market Size by Application (2016-2021)
9.3.2 Latin America Bi-Specific MAbS Market Size by Application (2022-2027)
9.3.3 Latin America Bi-Specific MAbS Market Size by Application (2016-2027)
9.4 Latin America Bi-Specific MAbS Market Size by Country
9.4.1 Latin America Bi-Specific MAbS Market Size by Country (2016-2021)
9.4.2 Latin America Bi-Specific MAbS Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bi-Specific MAbS Market Size (2016-2027)
10.2 Middle East & Africa Bi-Specific MAbS Market Size by Type
10.2.1 Middle East & Africa Bi-Specific MAbS Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bi-Specific MAbS Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bi-Specific MAbS Market Size by Type (2016-2027)
10.3 Middle East & Africa Bi-Specific MAbS Market Size by Application
10.3.1 Middle East & Africa Bi-Specific MAbS Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bi-Specific MAbS Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bi-Specific MAbS Market Size by Application (2016-2027)
10.4 Middle East & Africa Bi-Specific MAbS Market Size by Country
10.4.1 Middle East & Africa Bi-Specific MAbS Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bi-Specific MAbS Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Bi-Specific MAbS Introduction
11.1.4 Johnson and Johnson Revenue in Bi-Specific MAbS Business (2016-2021)
11.1.5 Johnson and Johnson Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Bi-Specific MAbS Introduction
11.2.4 Novartis AG Revenue in Bi-Specific MAbS Business (2016-2021)
11.2.5 Novartis AG Recent Development
11.3 Hoffmann-La Roche Ltd.
11.3.1 Hoffmann-La Roche Ltd. Company Details
11.3.2 Hoffmann-La Roche Ltd. Business Overview
11.3.3 Hoffmann-La Roche Ltd. Bi-Specific MAbS Introduction
11.3.4 Hoffmann-La Roche Ltd. Revenue in Bi-Specific MAbS Business (2016-2021)
11.3.5 Hoffmann-La Roche Ltd. Recent Development
11.4 Chugai Pharmaceutical
11.4.1 Chugai Pharmaceutical Company Details
11.4.2 Chugai Pharmaceutical Business Overview
11.4.3 Chugai Pharmaceutical Bi-Specific MAbS Introduction
11.4.4 Chugai Pharmaceutical Revenue in Bi-Specific MAbS Business (2016-2021)
11.4.5 Chugai Pharmaceutical Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Bi-Specific MAbS Introduction
11.5.4 Bayer AG Revenue in Bi-Specific MAbS Business (2016-2021)
11.5.5 Bayer AG Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Bi-Specific MAbS Introduction
11.6.4 Thermo Fisher Scientific Revenue in Bi-Specific MAbS Business (2016-2021)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Bistro-Myers Squibb
11.7.1 Bistro-Myers Squibb Company Details
11.7.2 Bistro-Myers Squibb Business Overview
11.7.3 Bistro-Myers Squibb Bi-Specific MAbS Introduction
11.7.4 Bistro-Myers Squibb Revenue in Bi-Specific MAbS Business (2016-2021)
11.7.5 Bistro-Myers Squibb Recent Development
11.8 Mylan N.V.
11.8.1 Mylan N.V. Company Details
11.8.2 Mylan N.V. Business Overview
11.8.3 Mylan N.V. Bi-Specific MAbS Introduction
11.8.4 Mylan N.V. Revenue in Bi-Specific MAbS Business (2016-2021)
11.8.5 Mylan N.V. Recent Development
11.9 Daiichi Sankyo Company
11.9.1 Daiichi Sankyo Company Company Details
11.9.2 Daiichi Sankyo Company Business Overview
11.9.3 Daiichi Sankyo Company Bi-Specific MAbS Introduction
11.9.4 Daiichi Sankyo Company Revenue in Bi-Specific MAbS Business (2016-2021)
11.9.5 Daiichi Sankyo Company Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Bi-Specific MAbS Introduction
11.10.4 Abbott Revenue in Bi-Specific MAbS Business (2016-2021)
11.10.5 Abbott Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Bi-Specific MAbS Introduction
11.11.4 AstraZeneca Revenue in Bi-Specific MAbS Business (2016-2021)
11.11.5 AstraZeneca Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Details
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Bi-Specific MAbS Introduction
11.12.4 Eli Lilly Revenue in Bi-Specific MAbS Business (2016-2021)
11.12.5 Eli Lilly Recent Development
11.13 Merck and Co.
11.13.1 Merck and Co. Company Details
11.13.2 Merck and Co. Business Overview
11.13.3 Merck and Co. Bi-Specific MAbS Introduction
11.13.4 Merck and Co. Revenue in Bi-Specific MAbS Business (2016-2021)
11.13.5 Merck and Co. Recent Development
11.14 Amgen
11.14.1 Amgen Company Details
11.14.2 Amgen Business Overview
11.14.3 Amgen Bi-Specific MAbS Introduction
11.14.4 Amgen Revenue in Bi-Specific MAbS Business (2016-2021)
11.14.5 Amgen Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Bi-Specific MAbS Introduction
11.15.4 Pfizer Revenue in Bi-Specific MAbS Business (2016-2021)
11.15.5 Pfizer Recent Development
11.16 GlaxoSmithKline plc
11.16.1 GlaxoSmithKline plc Company Details
11.16.2 GlaxoSmithKline plc Business Overview
11.16.3 GlaxoSmithKline plc Bi-Specific MAbS Introduction
11.16.4 GlaxoSmithKline plc Revenue in Bi-Specific MAbS Business (2016-2021)
11.16.5 GlaxoSmithKline plc Recent Development
11.17 Roche
11.17.1 Roche Company Details
11.17.2 Roche Business Overview
11.17.3 Roche Bi-Specific MAbS Introduction
11.17.4 Roche Revenue in Bi-Specific MAbS Business (2016-2021)
11.17.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Bi-Specific MAbS Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Bi-Specific MAbS Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Catumaxomab
Table 3. Key Players of Blinatumomab
Table 4. Key Players of Duligotumab
Table 5. Key Players of SAR 156597
Table 6. Global Bi-Specific MAbS Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bi-Specific MAbS Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Bi-Specific MAbS Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Bi-Specific MAbS Market Share by Regions (2016-2021)
Table 10. Global Bi-Specific MAbS Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Bi-Specific MAbS Market Share by Regions (2022-2027)
Table 12. Bi-Specific MAbS Market Trends
Table 13. Bi-Specific MAbS Market Drivers
Table 14. Bi-Specific MAbS Market Challenges
Table 15. Bi-Specific MAbS Market Restraints
Table 16. Global Bi-Specific MAbS Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Bi-Specific MAbS Market Share by Players (2016-2021)
Table 18. Global Top Bi-Specific MAbS Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bi-Specific MAbS as of 2020)
Table 19. Ranking of Global Top Bi-Specific MAbS Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Bi-Specific MAbS Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Bi-Specific MAbS Product Solution and Service
Table 23. Date of Enter into Bi-Specific MAbS Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bi-Specific MAbS Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Bi-Specific MAbS Revenue Market Share by Type (2016-2021)
Table 27. Global Bi-Specific MAbS Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Bi-Specific MAbS Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Bi-Specific MAbS Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Bi-Specific MAbS Revenue Market Share by Application (2016-2021)
Table 31. Global Bi-Specific MAbS Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Bi-Specific MAbS Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Bi-Specific MAbS Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Bi-Specific MAbS Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Bi-Specific MAbS Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Bi-Specific MAbS Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Bi-Specific MAbS Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Bi-Specific MAbS Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Bi-Specific MAbS Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Bi-Specific MAbS Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Bi-Specific MAbS Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Bi-Specific MAbS Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Bi-Specific MAbS Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Bi-Specific MAbS Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bi-Specific MAbS Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bi-Specific MAbS Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bi-Specific MAbS Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Bi-Specific MAbS Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Bi-Specific MAbS Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Bi-Specific MAbS Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Bi-Specific MAbS Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Bi-Specific MAbS Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Bi-Specific MAbS Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Bi-Specific MAbS Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Bi-Specific MAbS Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Bi-Specific MAbS Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bi-Specific MAbS Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bi-Specific MAbS Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bi-Specific MAbS Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Bi-Specific MAbS Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Bi-Specific MAbS Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Bi-Specific MAbS Market Size by Country (2022-2027) & (US$ Million)
Table 63. Johnson and Johnson Company Details
Table 64. Johnson and Johnson Business Overview
Table 65. Johnson and Johnson Bi-Specific MAbS Product
Table 66. Johnson and Johnson Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 67. Johnson and Johnson Recent Development
Table 68. Novartis AG Company Details
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Bi-Specific MAbS Product
Table 71. Novartis AG Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 72. Novartis AG Recent Development
Table 73. Hoffmann-La Roche Ltd. Company Details
Table 74. Hoffmann-La Roche Ltd. Business Overview
Table 75. Hoffmann-La Roche Ltd. Bi-Specific MAbS Product
Table 76. Hoffmann-La Roche Ltd. Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 77. Hoffmann-La Roche Ltd. Recent Development
Table 78. Chugai Pharmaceutical Company Details
Table 79. Chugai Pharmaceutical Business Overview
Table 80. Chugai Pharmaceutical Bi-Specific MAbS Product
Table 81. Chugai Pharmaceutical Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 82. Chugai Pharmaceutical Recent Development
Table 83. Bayer AG Company Details
Table 84. Bayer AG Business Overview
Table 85. Bayer AG Bi-Specific MAbS Product
Table 86. Bayer AG Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 87. Bayer AG Recent Development
Table 88. Thermo Fisher Scientific Company Details
Table 89. Thermo Fisher Scientific Business Overview
Table 90. Thermo Fisher Scientific Bi-Specific MAbS Product
Table 91. Thermo Fisher Scientific Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 92. Thermo Fisher Scientific Recent Development
Table 93. Bistro-Myers Squibb Company Details
Table 94. Bistro-Myers Squibb Business Overview
Table 95. Bistro-Myers Squibb Bi-Specific MAbS Product
Table 96. Bistro-Myers Squibb Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 97. Bistro-Myers Squibb Recent Development
Table 98. Mylan N.V. Company Details
Table 99. Mylan N.V. Business Overview
Table 100. Mylan N.V. Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 101. Mylan N.V. Recent Development
Table 102. Daiichi Sankyo Company Company Details
Table 103. Daiichi Sankyo Company Business Overview
Table 104. Daiichi Sankyo Company Bi-Specific MAbS Product
Table 105. Daiichi Sankyo Company Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 106. Daiichi Sankyo Company Recent Development
Table 107. Abbott Company Details
Table 108. Abbott Business Overview
Table 109. Abbott Bi-Specific MAbS Product
Table 110. Abbott Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 111. Abbott Recent Development
Table 112. AstraZeneca Company Details
Table 113. AstraZeneca Business Overview
Table 114. AstraZeneca Bi-Specific MAbS Product
Table 115. AstraZeneca Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 116. AstraZeneca Recent Development
Table 117. Eli Lilly Company Details
Table 118. Eli Lilly Business Overview
Table 119. Eli Lilly Bi-Specific MAbS Product
Table 120. Eli Lilly Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 121. Eli Lilly Recent Development
Table 122. Merck and Co. Company Details
Table 123. Merck and Co. Business Overview
Table 124. Merck and Co. Bi-Specific MAbS Product
Table 125. Merck and Co. Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 126. Merck and Co. Recent Development
Table 127. Amgen Company Details
Table 128. Amgen Business Overview
Table 129. Amgen Bi-Specific MAbS Product
Table 130. Amgen Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 131. Amgen Recent Development
Table 132. Pfizer Company Details
Table 133. Pfizer Business Overview
Table 134. Pfizer Bi-Specific MAbS Product
Table 135. Pfizer Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 136. Pfizer Recent Development
Table 137. GlaxoSmithKline plc Company Details
Table 138. GlaxoSmithKline plc Business Overview
Table 139. GlaxoSmithKline plc Bi-Specific MAbS Product
Table 140. GlaxoSmithKline plc Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 141. GlaxoSmithKline plc Recent Development
Table 142. Roche Company Details
Table 143. Roche Business Overview
Table 144. Roche Bi-Specific MAbS Product
Table 145. Roche Revenue in Bi-Specific MAbS Business (2016-2021) & (US$ Million)
Table 146. Roche Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bi-Specific MAbS Market Share by Type: 2020 VS 2027
Figure 2. Catumaxomab Features
Figure 3. Blinatumomab Features
Figure 4. Duligotumab Features
Figure 5. SAR 156597 Features
Figure 6. Global Bi-Specific MAbS Market Share by Application: 2020 VS 2027
Figure 7. Cancer Case Studies
Figure 8. Autoimmune Diseases Case Studies
Figure 9. Inflammatory Diseases Case Studies
Figure 10. Infectious Diseases Case Studies
Figure 11. Microbial Diseases Case Studies
Figure 12. Others Case Studies
Figure 13. Bi-Specific MAbS Report Years Considered
Figure 14. Global Bi-Specific MAbS Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Bi-Specific MAbS Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Bi-Specific MAbS Market Share by Regions: 2020 VS 2027
Figure 17. Global Bi-Specific MAbS Market Share by Regions (2022-2027)
Figure 18. Global Bi-Specific MAbS Market Share by Players in 2020
Figure 19. Global Top Bi-Specific MAbS Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bi-Specific MAbS as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Bi-Specific MAbS Revenue in 2020
Figure 21. Global Bi-Specific MAbS Revenue Market Share by Type (2016-2021)
Figure 22. Global Bi-Specific MAbS Revenue Market Share by Type (2022-2027)
Figure 23. North America Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Bi-Specific MAbS Market Share by Type (2016-2027)
Figure 25. North America Bi-Specific MAbS Market Share by Application (2016-2027)
Figure 26. North America Bi-Specific MAbS Market Share by Country (2016-2027)
Figure 27. United States Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Bi-Specific MAbS Market Share by Type (2016-2027)
Figure 31. Europe Bi-Specific MAbS Market Share by Application (2016-2027)
Figure 32. Europe Bi-Specific MAbS Market Share by Country (2016-2027)
Figure 33. Germany Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Bi-Specific MAbS Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Bi-Specific MAbS Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Bi-Specific MAbS Market Share by Region (2016-2027)
Figure 43. China Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Bi-Specific MAbS Market Share by Type (2016-2027)
Figure 51. Latin America Bi-Specific MAbS Market Share by Application (2016-2027)
Figure 52. Latin America Bi-Specific MAbS Market Share by Country (2016-2027)
Figure 53. Mexico Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Bi-Specific MAbS Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Bi-Specific MAbS Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Bi-Specific MAbS Market Share by Country (2016-2027)
Figure 59. Turkey Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Bi-Specific MAbS Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Johnson and Johnson Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 63. Novartis AG Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 64. Hoffmann-La Roche Ltd. Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 65. Chugai Pharmaceutical Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 66. Bayer AG Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 68. Bistro-Myers Squibb Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 69. Mylan N.V. Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 70. Daiichi Sankyo Company Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 71. Abbott Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 72. AstraZeneca Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 73. Eli Lilly Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 74. Merck and Co. Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 75. Amgen Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 76. Pfizer Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 77. GlaxoSmithKline plc Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 78. Roche Revenue Growth Rate in Bi-Specific MAbS Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
Keyplayers in Global Bi-Specific MAbS Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bi-Specific MAbS Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Catumaxomab
1.2.3 Blinatumomab
1.2.4 Duligotumab
1.2.5 SAR 156597
1.3 Market by Application
1.3.1 Global Bi-Specific MAbS Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Inflammatory Diseases
1.3.5 Infectious Diseases
1.3.6 Microbial Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bi-Specific MAbS Market Perspective (2016-2027)
2.2 Bi-Specific MAbS Growth Trends by Regions
2.2.1 Bi-Specific MAbS Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bi-Specific MAbS Historic Market Share by Regions (2016-2021)
2.2.3 Bi-Specific MAbS Forecasted Market Size by Regions (2022-2027)
2.3 Bi-Specific MAbS Industry Dynamic
2.3.1 Bi-Specific MAbS Market Trends
2.3.2 Bi-Specific MAbS Market Drivers
2.3.3 Bi-Specific MAbS Market Challenges
2.3.4 Bi-Specific MAbS Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bi-Specific MAbS Players by Revenue
3.1.1 Global Top Bi-Specific MAbS Players by Revenue (2016-2021)
3.1.2 Global Bi-Specific MAbS Revenue Market Share by Players (2016-2021)
3.2 Global Bi-Specific MAbS Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bi-Specific MAbS Revenue
3.4 Global Bi-Specific MAbS Market Concentration Ratio
3.4.1 Global Bi-Specific MAbS Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bi-Specific MAbS Revenue in 2020
3.5 Bi-Specific MAbS Key Players Head office and Area Served
3.6 Key Players Bi-Specific MAbS Product Solution and Service
3.7 Date of Enter into Bi-Specific MAbS Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bi-Specific MAbS Breakdown Data by Type
4.1 Global Bi-Specific MAbS Historic Market Size by Type (2016-2021)
4.2 Global Bi-Specific MAbS Forecasted Market Size by Type (2022-2027)
5 Bi-Specific MAbS Breakdown Data by Application
5.1 Global Bi-Specific MAbS Historic Market Size by Application (2016-2021)
5.2 Global Bi-Specific MAbS Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Bi-Specific MAbS Market Size (2016-2027)
6.2 North America Bi-Specific MAbS Market Size by Type
6.2.1 North America Bi-Specific MAbS Market Size by Type (2016-2021)
6.2.2 North America Bi-Specific MAbS Market Size by Type (2022-2027)
6.2.3 North America Bi-Specific MAbS Market Size by Type (2016-2027)
6.3 North America Bi-Specific MAbS Market Size by Application
6.3.1 North America Bi-Specific MAbS Market Size by Application (2016-2021)
6.3.2 North America Bi-Specific MAbS Market Size by Application (2022-2027)
6.3.3 North America Bi-Specific MAbS Market Size by Application (2016-2027)
6.4 North America Bi-Specific MAbS Market Size by Country
6.4.1 North America Bi-Specific MAbS Market Size by Country (2016-2021)
6.4.2 North America Bi-Specific MAbS Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Bi-Specific MAbS Market Size (2016-2027)
7.2 Europe Bi-Specific MAbS Market Size by Type
7.2.1 Europe Bi-Specific MAbS Market Size by Type (2016-2021)
7.2.2 Europe Bi-Specific MAbS Market Size by Type (2022-2027)
7.2.3 Europe Bi-Specific MAbS Market Size by Type (2016-2027)
7.3 Europe Bi-Specific MAbS Market Size by Application
7.3.1 Europe Bi-Specific MAbS Market Size by Application (2016-2021)
7.3.2 Europe Bi-Specific MAbS Market Size by Application (2022-2027)
7.3.3 Europe Bi-Specific MAbS Market Size by Application (2016-2027)
7.4 Europe Bi-Specific MAbS Market Size by Country
7.4.1 Europe Bi-Specific MAbS Market Size by Country (2016-2021)
7.4.2 Europe Bi-Specific MAbS Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Bi-Specific MAbS Market Size (2016-2027)
8.2 Asia-Pacific Bi-Specific MAbS Market Size by Type
8.2.1 Asia-Pacific Bi-Specific MAbS Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bi-Specific MAbS Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bi-Specific MAbS Market Size by Type (2016-2027)
8.3 Asia-Pacific Bi-Specific MAbS Market Size by Application
8.3.1 Asia-Pacific Bi-Specific MAbS Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bi-Specific MAbS Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bi-Specific MAbS Market Size by Application (2016-2027)
8.4 Asia-Pacific Bi-Specific MAbS Market Size by Region
8.4.1 Asia-Pacific Bi-Specific MAbS Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bi-Specific MAbS Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bi-Specific MAbS Market Size (2016-2027)
9.2 Latin America Bi-Specific MAbS Market Size by Type
9.2.1 Latin America Bi-Specific MAbS Market Size by Type (2016-2021)
9.2.2 Latin America Bi-Specific MAbS Market Size by Type (2022-2027)
9.2.3 Latin America Bi-Specific MAbS Market Size by Type (2016-2027)
9.3 Latin America Bi-Specific MAbS Market Size by Application
9.3.1 Latin America Bi-Specific MAbS Market Size by Application (2016-2021)
9.3.2 Latin America Bi-Specific MAbS Market Size by Application (2022-2027)
9.3.3 Latin America Bi-Specific MAbS Market Size by Application (2016-2027)
9.4 Latin America Bi-Specific MAbS Market Size by Country
9.4.1 Latin America Bi-Specific MAbS Market Size by Country (2016-2021)
9.4.2 Latin America Bi-Specific MAbS Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bi-Specific MAbS Market Size (2016-2027)
10.2 Middle East & Africa Bi-Specific MAbS Market Size by Type
10.2.1 Middle East & Africa Bi-Specific MAbS Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bi-Specific MAbS Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bi-Specific MAbS Market Size by Type (2016-2027)
10.3 Middle East & Africa Bi-Specific MAbS Market Size by Application
10.3.1 Middle East & Africa Bi-Specific MAbS Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bi-Specific MAbS Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bi-Specific MAbS Market Size by Application (2016-2027)
10.4 Middle East & Africa Bi-Specific MAbS Market Size by Country
10.4.1 Middle East & Africa Bi-Specific MAbS Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bi-Specific MAbS Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Details
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Bi-Specific MAbS Introduction
11.1.4 Johnson and Johnson Revenue in Bi-Specific MAbS Business (2016-2021)
11.1.5 Johnson and Johnson Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Bi-Specific MAbS Introduction
11.2.4 Novartis AG Revenue in Bi-Specific MAbS Business (2016-2021)
11.2.5 Novartis AG Recent Development
11.3 Hoffmann-La Roche Ltd.
11.3.1 Hoffmann-La Roche Ltd. Company Details
11.3.2 Hoffmann-La Roche Ltd. Business Overview
11.3.3 Hoffmann-La Roche Ltd. Bi-Specific MAbS Introduction
11.3.4 Hoffmann-La Roche Ltd. Revenue in Bi-Specific MAbS Business (2016-2021)
11.3.5 Hoffmann-La Roche Ltd. Recent Development
11.4 Chugai Pharmaceutical
11.4.1 Chugai Pharmaceutical Company Details
11.4.2 Chugai Pharmaceutical Business Overview
11.4.3 Chugai Pharmaceutical Bi-Specific MAbS Introduction
11.4.4 Chugai Pharmaceutical Revenue in Bi-Specific MAbS Business (2016-2021)
11.4.5 Chugai Pharmaceutical Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Bi-Specific MAbS Introduction
11.5.4 Bayer AG Revenue in Bi-Specific MAbS Business (2016-2021)
11.5.5 Bayer AG Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Bi-Specific MAbS Introduction
11.6.4 Thermo Fisher Scientific Revenue in Bi-Specific MAbS Business (2016-2021)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Bistro-Myers Squibb
11.7.1 Bistro-Myers Squibb Company Details
11.7.2 Bistro-Myers Squibb Business Overview
11.7.3 Bistro-Myers Squibb Bi-Specific MAbS Introduction
11.7.4 Bistro-Myers Squibb Revenue in Bi-Specific MAbS Business (2016-2021)
11.7.5 Bistro-Myers Squibb Recent Development
11.8 Mylan N.V.
11.8.1 Mylan N.V. Company Details
11.8.2 Mylan N.V. Business Overview
11.8.3 Mylan N.V. Bi-Specific MAbS Introduction
11.8.4 Mylan N.V. Revenue in Bi-Specific MAbS Business (2016-2021)
11.8.5 Mylan N.V. Recent Development
11.9 Daiichi Sankyo Company
11.9.1 Daiichi Sankyo Company Company Details
11.9.2 Daiichi Sankyo Company Business Overview
11.9.3 Daiichi Sankyo Company Bi-Specific MAbS Introduction
11.9.4 Daiichi Sankyo Company Revenue in Bi-Specific MAbS Business (2016-2021)
11.9.5 Daiichi Sankyo Company Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Bi-Specific MAbS Introduction
11.10.4 Abbott Revenue in Bi-Specific MAbS Business (2016-2021)
11.10.5 Abbott Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Bi-Specific MAbS Introduction
11.11.4 AstraZeneca Revenue in Bi-Specific MAbS Business (2016-2021)
11.11.5 AstraZeneca Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Details
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Bi-Specific MAbS Introduction
11.12.4 Eli Lilly Revenue in Bi-Specific MAbS Business (2016-2021)
11.12.5 Eli Lilly Recent Development
11.13 Merck and Co.
11.13.1 Merck and Co. Company Details
11.13.2 Merck and Co. Business Overview
11.13.3 Merck and Co. Bi-Specific MAbS Introduction
11.13.4 Merck and Co. Revenue in Bi-Specific MAbS Business (2016-2021)
11.13.5 Merck and Co. Recent Development
11.14 Amgen
11.14.1 Amgen Company Details
11.14.2 Amgen Business Overview
11.14.3 Amgen Bi-Specific MAbS Introduction
11.14.4 Amgen Revenue in Bi-Specific MAbS Business (2016-2021)
11.14.5 Amgen Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Bi-Specific MAbS Introduction
11.15.4 Pfizer Revenue in Bi-Specific MAbS Business (2016-2021)
11.15.5 Pfizer Recent Development
11.16 GlaxoSmithKline plc
11.16.1 GlaxoSmithKline plc Company Details
11.16.2 GlaxoSmithKline plc Business Overview
11.16.3 GlaxoSmithKline plc Bi-Specific MAbS Introduction
11.16.4 GlaxoSmithKline plc Revenue in Bi-Specific MAbS Business (2016-2021)
11.16.5 GlaxoSmithKline plc Recent Development
11.17 Roche
11.17.1 Roche Company Details
11.17.2 Roche Business Overview
11.17.3 Roche Bi-Specific MAbS Introduction
11.17.4 Roche Revenue in Bi-Specific MAbS Business (2016-2021)
11.17.5 Roche Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details